This is challenging!
A 62-year-old experienced mining man John Waddell, from Arizona, USA went to an abandoned gold mine in the Agra Desert to search for gold. Unfortunately, an accident happened and he fell into a 30-meter-deep mine pit.
Online photo
He not only got trapped for 48 hours without any food or drinks, but also faced the attack of three rattlesnakes.
According to reports, Waddell told his friend Schrader on the 15th this month before he went for mining. He said Schrader that if he did not return on the 16th, Schrader should check his whereabouts.
Schrader came to the northwest of Phoenix on the 17th because of the disappearance of Waddell in the past few days. When he stopped his truck, he heard someone calling "help, help!" Schrader regretted not going early.
Online photo
Online photo
Schrader said that the pit where Waddell fell was in a remote area, and the mobile could not receive the signal. He could only drive the car out of the desert and call the emergency service personnel for rescue.
He also speculated that the fixed carabiner might be broken, so his friend Waddle fell. After being trapped for 48 hours, Waddle survived with neither food nor water, and multiple snake attacks.
Design photo
Rescuers team revealed that Waddell was severely dehydrated, had broken legs and bruised hands, but was able to speak when they found him. Waddell recalled killing three rattlesnakes with deadly venom.
The rescue team spent six hours to rescue Waddell and then aired him to the hospital for treatment. No serious injuries were found after checks.
LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine's safety, when dozens of countries suspended the vaccine's use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca's shot didn't raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
Billions of doses of the AstraZeneca vaccine were distributed to poorer countries through a U.N.-coordinated program, as it was cheaper and easier to produce and distribute. But studies later suggested that the pricier messenger RNA vaccines made by Pfizer-BioNTech and Moderna provided better protection against COVID-19 and its many variants, and most countries switched to those shots.
The U.K.'s national coronavirus immunization program in 2021 heavily relied on AstraZeneca's vaccine, which was largely developed by scientists at Oxford University with significant financial government support. But even Britain later resorted to buying the mRNA vaccines for its COVID booster vaccination programs and the AstraZeneca vaccine is now rarely used globally.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
FILE - Medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, Monday, March 22, 2021. The pharma giant AstraZeneca has requested that its European authorization for its COVID vaccine be pulled, according to the EU medicines regulator on Wednesday, May 8, 2024. (AP Photo/Matthias Schrader, FILE)
